These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 60287)
1. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. III. Alterations of splenic B and T cells in Friend virus-infected mice. Cerny J; Essex M; Thomas DB Int J Cancer; 1976 Aug; 18(2):197-204. PubMed ID: 60287 [TBL] [Abstract][Full Text] [Related]
2. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. II. Infections of B and T cells with Friend virus complex indiffusion chambers and in vitro: effect of polyclonal mitogens. Cerny J; Hensgen PA; Fistel SH; Demler LM Int J Cancer; 1976 Aug; 18(2):189-96. PubMed ID: 1085288 [TBL] [Abstract][Full Text] [Related]
3. Expression of virus-associated antigens and immune cell functions during spontaneous regression of the Friend viral murine leukemia. Cerny J; Essex M; Rich MA; Hardy WD Int J Cancer; 1975 Feb; 15(2):351-65. PubMed ID: 47847 [TBL] [Abstract][Full Text] [Related]
4. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. I. Virus replication in lymphocytes infected with Friend virus and cultures in diffusion chambers in vivo. Cerny J; Fistel SH; Hensgen PA Int J Cancer; 1976 Aug; 18(2):176-88. PubMed ID: 182644 [TBL] [Abstract][Full Text] [Related]
5. Lymphocyte surface receptors and leukemia virus-induced immunosuppression. Friedman H; Kateley JR Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386 [TBL] [Abstract][Full Text] [Related]
6. Specific susceptibility of sensitized (memory) B cells to suppression and antigenic alteration by murine leukemia virus. Cerny J; Waner EB J Immunol; 1975 Feb; 114(2 Pt 1):571-80. PubMed ID: 164504 [TBL] [Abstract][Full Text] [Related]
7. Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus. Risser R J Exp Med; 1979 May; 149(5):1152-67. PubMed ID: 448285 [TBL] [Abstract][Full Text] [Related]
8. Target cell heterogeneity in murine leukemia virus infection. II. Demonstration of Friend leukemia-virus-permissive and non-permissive subsets of splenic T cells. Isaak DD; Cerny J Int J Cancer; 1981; 27(4):505-12. PubMed ID: 6974139 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of genetic resistance to Friend virus leukemia. III. Susceptibility of mitogen-responsive lymphocytes mediated by T cells. Kumar V; Caruso T; Bennett M J Exp Med; 1976 Apr; 143(4):728-40. PubMed ID: 1082914 [TBL] [Abstract][Full Text] [Related]
10. Functional heterogeneity of murine lymphoid cells. V. Lymphocytes lacking detectable surface theta or immunoglobulin determinants. Stobo JD; Rosenthal AS; Paul WE J Exp Med; 1973 Jul; 138(1):71-88. PubMed ID: 4123830 [TBL] [Abstract][Full Text] [Related]
11. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease. Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628 [TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin and other surface antigens of cells of the immune system. Takahashi T; Old LJ; McIntire KR; Boyse EA J Exp Med; 1971 Oct; 134(4):815-32. PubMed ID: 4106485 [TBL] [Abstract][Full Text] [Related]
13. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy. Genovesi EV; Pettey CL; Collins JJ Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407 [TBL] [Abstract][Full Text] [Related]
14. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice. Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370 [TBL] [Abstract][Full Text] [Related]
15. Cell-free transmission of Fv-4 resistance gene product controlling Friend leukemia virus-induced leukemogenesis: a unique mechanism for interference with viral infection. Kitagawa M; Aizawa S; Kamisaku H; Ikeda H; Hirokawa K; Sado T Blood; 1995 Aug; 86(4):1557-63. PubMed ID: 7632964 [TBL] [Abstract][Full Text] [Related]
16. Phenotypic heterogeneity of leukemias associated with Friend MuLV infection: studies on T-cell lymphomas and null cell leukemias in euthymic and thymus-deficient mice. Isaak DD; Asjö B; Hoover EA; Cerny J Leuk Res; 1984; 8(4):617-27. PubMed ID: 6332242 [TBL] [Abstract][Full Text] [Related]
17. A detailed analysis of F-MuLV- and SFFV-infected cells in Friend virus-infected mice reveals the contribution of both F-MuLV- and SFFV-infected cells to the interleukin-10 host response. Podschwadt P; Malyshkina A; Windmann S; Werner T; Hansen W; Bayer W Retrovirology; 2022 Dec; 19(1):29. PubMed ID: 36527061 [TBL] [Abstract][Full Text] [Related]
18. Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genes. Miyazawa M; Nishio J; Chesebro B J Exp Med; 1988 Nov; 168(5):1587-605. PubMed ID: 3141552 [TBL] [Abstract][Full Text] [Related]
19. Virus and cell requirements for Friend virus granulocytic leukemogenesis in long-term bone marrow cultures of NIH swiss [N:NIH(S)] mice. Greenberger JS; Newburger PE; Lipton JM; Moloney WC; Sakakeeny MA; Jackson PL J Natl Cancer Inst; 1980 Apr; 64(4):867-78. PubMed ID: 6928998 [TBL] [Abstract][Full Text] [Related]
20. Target cell heterogeneity in murine leukemia virus infection. I. Differences in susceptibility to infection with Friend leukemia virus between B lymphocytes from spleen, bone marrow and lymph nodes. Isaak DD; Price JA; Reinisch CL; Cerny J J Immunol; 1979 Oct; 123(4):1822-8. PubMed ID: 314476 [No Abstract] [Full Text] [Related] [Next] [New Search]